nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Infestation NOS—Vemurafenib—skin cancer	0.00646	0.00646	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00641	0.00641	CcSEcCtD
Vancomycin—Extravasation—Fluorouracil—skin cancer	0.00624	0.00624	CcSEcCtD
Vancomycin—Tenderness—Fluorouracil—skin cancer	0.00624	0.00624	CcSEcCtD
Vancomycin—Hearing impaired—Temozolomide—skin cancer	0.0062	0.0062	CcSEcCtD
Vancomycin—Phlebitis—Bleomycin—skin cancer	0.0059	0.0059	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Vismodegib—skin cancer	0.00576	0.00576	CcSEcCtD
Vancomycin—Fatigue—Vismodegib—skin cancer	0.00575	0.00575	CcSEcCtD
Vancomycin—Oedema peripheral—Vemurafenib—skin cancer	0.00572	0.00572	CcSEcCtD
Vancomycin—Pain—Vismodegib—skin cancer	0.00571	0.00571	CcSEcCtD
Vancomycin—Constipation—Vismodegib—skin cancer	0.00571	0.00571	CcSEcCtD
Vancomycin—Connective tissue disorder—Vemurafenib—skin cancer	0.0057	0.0057	CcSEcCtD
Vancomycin—Infestation NOS—Imiquimod—skin cancer	0.00551	0.00551	CcSEcCtD
Vancomycin—Infestation—Imiquimod—skin cancer	0.00551	0.00551	CcSEcCtD
Vancomycin—Phlebitis—Dactinomycin—skin cancer	0.0055	0.0055	CcSEcCtD
Vancomycin—Erythema multiforme—Vemurafenib—skin cancer	0.00549	0.00549	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00547	0.00547	CcSEcCtD
Vancomycin—Gastrointestinal pain—Vismodegib—skin cancer	0.00546	0.00546	CcSEcCtD
Vancomycin—Urinary tract infection—Imiquimod—skin cancer	0.00536	0.00536	CcSEcCtD
Vancomycin—Abdominal pain—Vismodegib—skin cancer	0.00528	0.00528	CcSEcCtD
Vancomycin—Chills—Vemurafenib—skin cancer	0.00521	0.00521	CcSEcCtD
Vancomycin—Malnutrition—Vemurafenib—skin cancer	0.00505	0.00505	CcSEcCtD
Vancomycin—Erythema—Vemurafenib—skin cancer	0.00505	0.00505	CcSEcCtD
Vancomycin—Necrosis—Docetaxel—skin cancer	0.005	0.005	CcSEcCtD
Vancomycin—Thrombophlebitis—Temozolomide—skin cancer	0.00495	0.00495	CcSEcCtD
Vancomycin—Back pain—Vemurafenib—skin cancer	0.00489	0.00489	CcSEcCtD
Vancomycin—Connective tissue disorder—Imiquimod—skin cancer	0.00486	0.00486	CcSEcCtD
Vancomycin—Rigors—Docetaxel—skin cancer	0.00481	0.00481	CcSEcCtD
Vancomycin—Deafness—Temozolomide—skin cancer	0.00479	0.00479	CcSEcCtD
Vancomycin—Asthenia—Vismodegib—skin cancer	0.00479	0.00479	CcSEcCtD
Vancomycin—Pruritus—Vismodegib—skin cancer	0.00472	0.00472	CcSEcCtD
Vancomycin—Erythema multiforme—Imiquimod—skin cancer	0.00468	0.00468	CcSEcCtD
Vancomycin—Tinnitus—Imiquimod—skin cancer	0.00461	0.00461	CcSEcCtD
Vancomycin—Flushing—Imiquimod—skin cancer	0.00459	0.00459	CcSEcCtD
Vancomycin—Thrombophlebitis—Fluorouracil—skin cancer	0.00456	0.00456	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Temozolomide—skin cancer	0.00454	0.00454	CcSEcCtD
Vancomycin—Extravasation—Docetaxel—skin cancer	0.0045	0.0045	CcSEcCtD
Vancomycin—Chills—Imiquimod—skin cancer	0.00444	0.00444	CcSEcCtD
Vancomycin—Malnutrition—Imiquimod—skin cancer	0.00431	0.00431	CcSEcCtD
Vancomycin—Erythema—Imiquimod—skin cancer	0.00431	0.00431	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00427	0.00427	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00427	0.00427	CcSEcCtD
Vancomycin—Vomiting—Vismodegib—skin cancer	0.00424	0.00424	CcSEcCtD
Vancomycin—Rash—Vismodegib—skin cancer	0.00421	0.00421	CcSEcCtD
Vancomycin—Dermatitis—Vismodegib—skin cancer	0.0042	0.0042	CcSEcCtD
Vancomycin—Back pain—Imiquimod—skin cancer	0.00417	0.00417	CcSEcCtD
Vancomycin—Dermatitis bullous—Fluorouracil—skin cancer	0.00413	0.00413	CcSEcCtD
Vancomycin—Hearing impaired—Docetaxel—skin cancer	0.00413	0.00413	CcSEcCtD
Vancomycin—Anaphylactic shock—Vemurafenib—skin cancer	0.00412	0.00412	CcSEcCtD
Vancomycin—Infection—Vemurafenib—skin cancer	0.0041	0.0041	CcSEcCtD
Vancomycin—Nervous system disorder—Vemurafenib—skin cancer	0.00404	0.00404	CcSEcCtD
Vancomycin—Skin disorder—Vemurafenib—skin cancer	0.004	0.004	CcSEcCtD
Vancomycin—Nausea—Vismodegib—skin cancer	0.00396	0.00396	CcSEcCtD
Vancomycin—Hypokalaemia—Temozolomide—skin cancer	0.0039	0.0039	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00386	0.00386	CcSEcCtD
Vancomycin—Hypotension—Vemurafenib—skin cancer	0.00385	0.00385	CcSEcCtD
Vancomycin—Neutropenia—Dactinomycin—skin cancer	0.00383	0.00383	CcSEcCtD
Vancomycin—Palpitations—Imiquimod—skin cancer	0.00381	0.00381	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00364	0.00364	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00362	0.00362	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00356	0.00356	CcSEcCtD
Vancomycin—Fatigue—Vemurafenib—skin cancer	0.00355	0.00355	CcSEcCtD
Vancomycin—Constipation—Vemurafenib—skin cancer	0.00353	0.00353	CcSEcCtD
Vancomycin—Infection—Imiquimod—skin cancer	0.00349	0.00349	CcSEcCtD
Vancomycin—Neutropenia—Temozolomide—skin cancer	0.00347	0.00347	CcSEcCtD
Vancomycin—Nervous system disorder—Imiquimod—skin cancer	0.00345	0.00345	CcSEcCtD
Vancomycin—Tachycardia—Imiquimod—skin cancer	0.00343	0.00343	CcSEcCtD
Vancomycin—Skin disorder—Imiquimod—skin cancer	0.00342	0.00342	CcSEcCtD
Vancomycin—Agranulocytosis—Dactinomycin—skin cancer	0.00341	0.00341	CcSEcCtD
Vancomycin—Eosinophilia—Fluorouracil—skin cancer	0.00338	0.00338	CcSEcCtD
Vancomycin—Phlebitis—Docetaxel—skin cancer	0.00331	0.00331	CcSEcCtD
Vancomycin—Infestation NOS—Temozolomide—skin cancer	0.0033	0.0033	CcSEcCtD
Vancomycin—Infestation—Temozolomide—skin cancer	0.0033	0.0033	CcSEcCtD
Vancomycin—Thrombophlebitis—Docetaxel—skin cancer	0.00329	0.00329	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00328	0.00328	CcSEcCtD
Vancomycin—Flushing—Bleomycin—skin cancer	0.00326	0.00326	CcSEcCtD
Vancomycin—Body temperature increased—Vemurafenib—skin cancer	0.00326	0.00326	CcSEcCtD
Vancomycin—Urinary tract infection—Temozolomide—skin cancer	0.00321	0.00321	CcSEcCtD
Vancomycin—Deafness—Docetaxel—skin cancer	0.00319	0.00319	CcSEcCtD
Vancomycin—Insomnia—Imiquimod—skin cancer	0.00318	0.00318	CcSEcCtD
Vancomycin—Chills—Bleomycin—skin cancer	0.00315	0.00315	CcSEcCtD
Vancomycin—Dyspnoea—Imiquimod—skin cancer	0.00313	0.00313	CcSEcCtD
Vancomycin—Erythema multiforme—Dactinomycin—skin cancer	0.0031	0.0031	CcSEcCtD
Vancomycin—Erythema—Bleomycin—skin cancer	0.00306	0.00306	CcSEcCtD
Vancomycin—Infestation NOS—Fluorouracil—skin cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Infestation—Fluorouracil—skin cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Flushing—Dactinomycin—skin cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Hypersensitivity—Vemurafenib—skin cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Fatigue—Imiquimod—skin cancer	0.00303	0.00303	CcSEcCtD
Vancomycin—Pain—Imiquimod—skin cancer	0.00301	0.00301	CcSEcCtD
Vancomycin—Renal impairment—Docetaxel—skin cancer	0.003	0.003	CcSEcCtD
Vancomycin—Dermatitis bullous—Docetaxel—skin cancer	0.00298	0.00298	CcSEcCtD
Vancomycin—Urinary tract infection—Fluorouracil—skin cancer	0.00296	0.00296	CcSEcCtD
Vancomycin—Asthenia—Vemurafenib—skin cancer	0.00296	0.00296	CcSEcCtD
Vancomycin—Chills—Dactinomycin—skin cancer	0.00294	0.00294	CcSEcCtD
Vancomycin—Oedema peripheral—Temozolomide—skin cancer	0.00292	0.00292	CcSEcCtD
Vancomycin—Pruritus—Vemurafenib—skin cancer	0.00292	0.00292	CcSEcCtD
Vancomycin—Connective tissue disorder—Temozolomide—skin cancer	0.00291	0.00291	CcSEcCtD
Vancomycin—Gastrointestinal pain—Imiquimod—skin cancer	0.00288	0.00288	CcSEcCtD
Vancomycin—Erythema—Dactinomycin—skin cancer	0.00285	0.00285	CcSEcCtD
Vancomycin—Agranulocytosis—Fluorouracil—skin cancer	0.00284	0.00284	CcSEcCtD
Vancomycin—Anaemia—Bleomycin—skin cancer	0.00283	0.00283	CcSEcCtD
Vancomycin—Erythema multiforme—Temozolomide—skin cancer	0.0028	0.0028	CcSEcCtD
Vancomycin—Urticaria—Imiquimod—skin cancer	0.00279	0.00279	CcSEcCtD
Vancomycin—Abdominal pain—Imiquimod—skin cancer	0.00278	0.00278	CcSEcCtD
Vancomycin—Body temperature increased—Imiquimod—skin cancer	0.00278	0.00278	CcSEcCtD
Vancomycin—Tinnitus—Temozolomide—skin cancer	0.00277	0.00277	CcSEcCtD
Vancomycin—Flushing—Temozolomide—skin cancer	0.00275	0.00275	CcSEcCtD
Vancomycin—Dizziness—Vemurafenib—skin cancer	0.00273	0.00273	CcSEcCtD
Vancomycin—Chills—Temozolomide—skin cancer	0.00266	0.00266	CcSEcCtD
Vancomycin—Anaemia—Dactinomycin—skin cancer	0.00264	0.00264	CcSEcCtD
Vancomycin—Vomiting—Vemurafenib—skin cancer	0.00262	0.00262	CcSEcCtD
Vancomycin—Rash—Vemurafenib—skin cancer	0.0026	0.0026	CcSEcCtD
Vancomycin—Dermatitis—Vemurafenib—skin cancer	0.0026	0.0026	CcSEcCtD
Vancomycin—Hypersensitivity—Imiquimod—skin cancer	0.00259	0.00259	CcSEcCtD
Vancomycin—Headache—Vemurafenib—skin cancer	0.00258	0.00258	CcSEcCtD
Vancomycin—Malnutrition—Temozolomide—skin cancer	0.00258	0.00258	CcSEcCtD
Vancomycin—Erythema—Temozolomide—skin cancer	0.00258	0.00258	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00257	0.00257	CcSEcCtD
Vancomycin—Asthenia—Imiquimod—skin cancer	0.00252	0.00252	CcSEcCtD
Vancomycin—Anaphylactic shock—Bleomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Vancomycin—Back pain—Temozolomide—skin cancer	0.0025	0.0025	CcSEcCtD
Vancomycin—Pruritus—Imiquimod—skin cancer	0.00249	0.00249	CcSEcCtD
Vancomycin—Infection—Bleomycin—skin cancer	0.00248	0.00248	CcSEcCtD
Vancomycin—Nausea—Vemurafenib—skin cancer	0.00245	0.00245	CcSEcCtD
Vancomycin—Thrombocytopenia—Bleomycin—skin cancer	0.00245	0.00245	CcSEcCtD
Vancomycin—Anaemia—Temozolomide—skin cancer	0.00239	0.00239	CcSEcCtD
Vancomycin—Erythema—Fluorouracil—skin cancer	0.00238	0.00238	CcSEcCtD
Vancomycin—Hypotension—Bleomycin—skin cancer	0.00233	0.00233	CcSEcCtD
Vancomycin—Dizziness—Imiquimod—skin cancer	0.00233	0.00233	CcSEcCtD
Vancomycin—Vertigo—Temozolomide—skin cancer	0.00232	0.00232	CcSEcCtD
Vancomycin—Infection—Dactinomycin—skin cancer	0.00231	0.00231	CcSEcCtD
Vancomycin—Neutropenia—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Vancomycin—Palpitations—Temozolomide—skin cancer	0.00228	0.00228	CcSEcCtD
Vancomycin—Thrombocytopenia—Dactinomycin—skin cancer	0.00228	0.00228	CcSEcCtD
Vancomycin—Vomiting—Imiquimod—skin cancer	0.00224	0.00224	CcSEcCtD
Vancomycin—Dyspnoea—Bleomycin—skin cancer	0.00223	0.00223	CcSEcCtD
Vancomycin—Rash—Imiquimod—skin cancer	0.00222	0.00222	CcSEcCtD
Vancomycin—Dermatitis—Imiquimod—skin cancer	0.00222	0.00222	CcSEcCtD
Vancomycin—Headache—Imiquimod—skin cancer	0.0022	0.0022	CcSEcCtD
Vancomycin—Anaemia—Fluorouracil—skin cancer	0.0022	0.0022	CcSEcCtD
Vancomycin—Infestation NOS—Docetaxel—skin cancer	0.0022	0.0022	CcSEcCtD
Vancomycin—Infestation—Docetaxel—skin cancer	0.0022	0.0022	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00218	0.00218	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00218	0.00218	CcSEcCtD
Vancomycin—Renal failure—Docetaxel—skin cancer	0.00216	0.00216	CcSEcCtD
Vancomycin—Pain—Bleomycin—skin cancer	0.00214	0.00214	CcSEcCtD
Vancomycin—Anaphylactic shock—Temozolomide—skin cancer	0.00211	0.00211	CcSEcCtD
Vancomycin—Infection—Temozolomide—skin cancer	0.00209	0.00209	CcSEcCtD
Vancomycin—Nausea—Imiquimod—skin cancer	0.00209	0.00209	CcSEcCtD
Vancomycin—Nervous system disorder—Temozolomide—skin cancer	0.00207	0.00207	CcSEcCtD
Vancomycin—Thrombocytopenia—Temozolomide—skin cancer	0.00206	0.00206	CcSEcCtD
Vancomycin—Agranulocytosis—Docetaxel—skin cancer	0.00205	0.00205	CcSEcCtD
Vancomycin—Skin disorder—Temozolomide—skin cancer	0.00205	0.00205	CcSEcCtD
Vancomycin—Fatigue—Dactinomycin—skin cancer	0.00201	0.00201	CcSEcCtD
Vancomycin—Pain—Dactinomycin—skin cancer	0.00199	0.00199	CcSEcCtD
Vancomycin—Urticaria—Bleomycin—skin cancer	0.00198	0.00198	CcSEcCtD
Vancomycin—Body temperature increased—Bleomycin—skin cancer	0.00197	0.00197	CcSEcCtD
Vancomycin—Oedema peripheral—Docetaxel—skin cancer	0.00194	0.00194	CcSEcCtD
Vancomycin—Anaphylactic shock—Fluorouracil—skin cancer	0.00194	0.00194	CcSEcCtD
Vancomycin—Connective tissue disorder—Docetaxel—skin cancer	0.00194	0.00194	CcSEcCtD
Vancomycin—Infection—Fluorouracil—skin cancer	0.00193	0.00193	CcSEcCtD
Vancomycin—Insomnia—Temozolomide—skin cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Gastrointestinal pain—Dactinomycin—skin cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Nervous system disorder—Fluorouracil—skin cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Thrombocytopenia—Fluorouracil—skin cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Tachycardia—Fluorouracil—skin cancer	0.00189	0.00189	CcSEcCtD
Vancomycin—Dyspnoea—Temozolomide—skin cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Erythema multiforme—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Vancomycin—Abdominal pain—Dactinomycin—skin cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Body temperature increased—Dactinomycin—skin cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Hypersensitivity—Bleomycin—skin cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Flushing—Docetaxel—skin cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Temozolomide—skin cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Fatigue—Temozolomide—skin cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Hypotension—Fluorouracil—skin cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Pain—Temozolomide—skin cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Constipation—Temozolomide—skin cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Asthenia—Bleomycin—skin cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Chills—Docetaxel—skin cancer	0.00177	0.00177	CcSEcCtD
Vancomycin—Pruritus—Bleomycin—skin cancer	0.00177	0.00177	CcSEcCtD
Vancomycin—Insomnia—Fluorouracil—skin cancer	0.00176	0.00176	CcSEcCtD
Vancomycin—Dyspnoea—Fluorouracil—skin cancer	0.00173	0.00173	CcSEcCtD
Vancomycin—Gastrointestinal pain—Temozolomide—skin cancer	0.00172	0.00172	CcSEcCtD
Vancomycin—Malnutrition—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Vancomycin—Erythema—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Vancomycin—Hypersensitivity—Dactinomycin—skin cancer	0.00172	0.00172	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Urticaria—Temozolomide—skin cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Asthenia—Dactinomycin—skin cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Abdominal pain—Temozolomide—skin cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Body temperature increased—Temozolomide—skin cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Back pain—Docetaxel—skin cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Pain—Fluorouracil—skin cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Muscle spasms—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Vomiting—Bleomycin—skin cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Anaemia—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Rash—Bleomycin—skin cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Dermatitis—Bleomycin—skin cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Hypersensitivity—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Urticaria—Fluorouracil—skin cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Body temperature increased—Fluorouracil—skin cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Palpitations—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Asthenia—Temozolomide—skin cancer	0.00151	0.00151	CcSEcCtD
Vancomycin—Pruritus—Temozolomide—skin cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Nausea—Bleomycin—skin cancer	0.00148	0.00148	CcSEcCtD
Vancomycin—Vomiting—Dactinomycin—skin cancer	0.00148	0.00148	CcSEcCtD
Vancomycin—Rash—Dactinomycin—skin cancer	0.00147	0.00147	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Hypersensitivity—Fluorouracil—skin cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Anaphylactic shock—Docetaxel—skin cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Dizziness—Temozolomide—skin cancer	0.00139	0.00139	CcSEcCtD
Vancomycin—Infection—Docetaxel—skin cancer	0.00139	0.00139	CcSEcCtD
Vancomycin—Nausea—Dactinomycin—skin cancer	0.00138	0.00138	CcSEcCtD
Vancomycin—Nervous system disorder—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Pruritus—Fluorouracil—skin cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Thrombocytopenia—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Tachycardia—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Skin disorder—Docetaxel—skin cancer	0.00136	0.00136	CcSEcCtD
Vancomycin—Vomiting—Temozolomide—skin cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Rash—Temozolomide—skin cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Dermatitis—Temozolomide—skin cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Headache—Temozolomide—skin cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Hypotension—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Dizziness—Fluorouracil—skin cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Insomnia—Docetaxel—skin cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Nausea—Temozolomide—skin cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Dyspnoea—Docetaxel—skin cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Vomiting—Fluorouracil—skin cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Rash—Fluorouracil—skin cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Dermatitis—Fluorouracil—skin cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Headache—Fluorouracil—skin cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Docetaxel—skin cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Fatigue—Docetaxel—skin cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Pain—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Constipation—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Nausea—Fluorouracil—skin cancer	0.00115	0.00115	CcSEcCtD
Vancomycin—Gastrointestinal pain—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Vancomycin—Abdominal pain—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Vancomycin—Body temperature increased—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Vancomycin—Hypersensitivity—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Vancomycin—Asthenia—Docetaxel—skin cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Pruritus—Docetaxel—skin cancer	0.000991	0.000991	CcSEcCtD
Vancomycin—Dizziness—Docetaxel—skin cancer	0.000927	0.000927	CcSEcCtD
Vancomycin—Vomiting—Docetaxel—skin cancer	0.000891	0.000891	CcSEcCtD
Vancomycin—Rash—Docetaxel—skin cancer	0.000884	0.000884	CcSEcCtD
Vancomycin—Dermatitis—Docetaxel—skin cancer	0.000883	0.000883	CcSEcCtD
Vancomycin—Headache—Docetaxel—skin cancer	0.000878	0.000878	CcSEcCtD
Vancomycin—Nausea—Docetaxel—skin cancer	0.000832	0.000832	CcSEcCtD
